Diligence memo · auto-generated · as of July 2, 2026
Endotronix Inc
Endotronix Inc looks over-valued against its niche peers and is dormant on financing cadence.
Businessfiled
Endotronix Inc operates in Other Health Care, based in LISLE.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Endotronix Inc has raised $116M in disclosed capital across 7 recorded rounds, aggregated from public filings. Its latest round is modeled as Series C (a $40M–$100M round).
Largest single filing: $69M on 2018-09-14.
Most recent recorded round closed around 2018-09-14.
Valuation (modeled)modeled
Provath models Endotronix Inc at approximately $1.6B (range $252M–$4.2B). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Over-valued. Modeled value is 1.52× the median modeled value of Series C Other Health Care companies in 2016–2018 (40 peers) — value vs value, same stage and era.
Financing rhythm & timingmixed
Historic cadence: a new round about every 8 months.
Last raise 7.8 yr ago; this sector typically re-raises about every 14 months.
Silent for over 3× the sector's normal cadence.
The last round stepped up 3.4× from the prior — scaling.
Comparablesmixed
Capital scale ranks ahead of 97% of Other Health Care peers (5377 compared).
Modeled value ranks above 98% of those peers.
Closest niche peers: Specialty Networks, LLC, New MMI Holdings, Inc., BioMatrix Holdings, L.L.C., Sea Hunter Holdings, LLC, Bind Benefits, Inc..
Peoplefiled
22 named people on file across officers, directors and signatories.
Risks & flagsmixed
Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.
Modeled above niche peers — valuation risk on entry.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.